INTRODUCTION
============

Resistance exercise (RE) is often used as a nonpharmacological tool for treatment and prevention of cardiovascular diseases ([@b21-jer-14-3-399]), leading to improvements in musculoskeletal, metabolic, and cardiovascular systems ([@b14-jer-14-3-399]). It has been reported that acute RE can reduce blood pressure ([@b21-jer-14-3-399]), a condition denominated post-exercise hypotension (PEH), and has an essential contribution in controlling high blood pressure ([@b10-jer-14-3-399]). Previous studies have investigated the effects of an acute RE program on blood pressure response, showing that intensity, volume, rest interval between sets, and amount of active muscle mass in RE can influence the magnitude or duration of PEH ([@b6-jer-14-3-399]; [@b9-jer-14-3-399]; [@b23-jer-14-3-399]; [@b25-jer-14-3-399]). Besides this, blood pressure responses are modulated by the autonomic nervous system ([@b15-jer-14-3-399]; [@b18-jer-14-3-399]).

The autonomic nervous system can be evaluated using heart rate variability, an accepted method to analyze changes which influence the cardiovascular system ([@b4-jer-14-3-399]). Previous studies have demonstrated that heart rate variability can be used to evaluate cardiovascular overload and stress induced by exercise ([@b1-jer-14-3-399]; [@b26-jer-14-3-399]). Heart rate variability indices can also be applied to measure autonomic modulation during recovery as well as parasympathetic reactivation after a bout of exercise ([@b17-jer-14-3-399]; [@b26-jer-14-3-399]). It has been reported that RE can drastically reduce parasympathetic modulation ([@b12-jer-14-3-399]; [@b13-jer-14-3-399]) and reductions in heart rate variability are related with cardiovascular events such as ventricular arrhythmias and sudden cardiac death as well as increased mortality risk ([@b22-jer-14-3-399]; [@b29-jer-14-3-399]; [@b30-jer-14-3-399]). In this sense, evaluation of autonomic modulation after acute bouts of RE with different program structures may have great clinical implications on RE prescription for healthy and cardiac patients.

Regarding investigation of the effects of RE with different limbs on PEH. [@b23-jer-14-3-399] demonstrated that significant reductions in systolic blood pressure (SBP) and mean blood pressure (MBP) only occur in lower body RE (leg extension, 10 sets with 10 repetitions), without significant results in upper body RE (biceps curl, 10 sets with 10 repetitions), suggesting the amount of active muscle mass during RE has an influence on PEH. To our knowledge, only one study compared the influence of acute full versus upper and lower body routines on heart rate variability in trained men and woman. [@b16-jer-14-3-399] observed that postexercise autonomic modulation was similar between conditions, while 25 min after exercise parasympathetic modulation was lower compared with rest. However, the study conducted by [@b16-jer-14-3-399] did not investigate blood pressure response, as the comparison between full versus split body routines on PEH is less explored in the literature.

From a practical point of view, it is necessary to understand the influence of RE with different routines (full or split body) on PEH and heart rate variability, since the results of this study could be used to direct the prescription of RE for blood pressure control. Thus, the purposes of this study were to investigate the effects of full versus split body RE on PEH and autonomic modulation in resistance-trained men.

MATERIALS AND METHODS
=====================

Participants
------------

Sixteen recreationally resistance trained males (age, 24.9±5.3 years; body weight, 78.5±11.9 kg; height, 179.0±8.7 cm) with a minimal 6 months of resistance training experience (experience, 4.5±2.8 years; weekly frequency training, 4.1±0.8 days) were recruited for this study. The inclusion criteria were: (a) aged between 20 and 30 years; (b) participates in regimented strength training ≥6 months ([@b2-jer-14-3-399]); (c) had not used any ergogenic substance or medicine for at least 6 mo [@b19-jer-14-3-399] nths prior to the study; (d) no smoking or alcohol use; (e) no contraindications involving the cardiovascular system. The study was approved by the Ethics in Research Group of the University of São Judas, São Paulo-SP, Brazil (protocol number: 66523717. 2.0000.0089) and the research was conducted according to the 2008 Revision of the Declaration of Helsinki. All participants signed a consent form and were informed about the purpose of the study and the possible risks.

Experimental design
-------------------

This study used a randomized and cross-over design. Subjects completed six experimental trials. The first visit was used to determine anthropometric measurements to characterize the sample. In the following two visits, one maximum repetition (1RM) test was performed for upper or lower body separated by 72 hr. In the fourth, fifth, and sixth visits, the participants randomly completed three experimental trials (full, upper, or lower body RE) separated by one week. All trials were performed at the same time (6:30 a.m. to 9:30 a.m.) to ensure chronobiological control. Heart rate variability and blood pressure were analyzed at rest in the supine position, immediately after the acute bout of RE, according to the experimental design shown in [Fig. 1](#f1-jer-14-3-399){ref-type="fig"}.

Anthropometric measurements and dietary intake assessment
---------------------------------------------------------

Electronic scale (Filizola PL 50, Filizzola Ltda., São Paulo, Brazil) with a precision of 0.1 kg was used to determine body weight and a fixed stadiometer of the Sanny brand, (Sanny brand, American Medical of Brazil Ltda, São Paulo, Brazil) with an accuracy of 0.1 cm and length of 2.20 m was used to measured height of the participants. The participants were positioning with their backs, shoulder blades, buttocks, and heels touching the stadiometer and they were wearing light clothing during assessment.

To guarantee participants presented equivalent conditions regarding energy, food questionnaires were distributed to all participants to record food intake for 3 days prior to each trial and a breakfast was provided to participants every day before the workout (1 hr 30 min), consisting of 15%--20% protein, 50%--60% carbohydrates, and 25%--30% fat, according to the American Heart Association ([@b19-jer-14-3-399]). Participants were instructed by a nutritionist as to how to complete the dietary questionnaires. All questionnaires were analyzed for total kilocalorie and macronutrient intake, averaged for the three days of trials to ensure that dietary intake was similar between experimental trials. The software (Software - Dietpro version 5.8, Nutrition Software, Viçosa, Brazil) utilized the database of Brazilian food composition table (TACO) to calculate dietary intake.

Strength test and RE protocol
-----------------------------

Initially, the participants completed two sessions to become acquainted with the equipment and perform strength test procedures. A warm-up was performed prior to 1RM testing, which consisted of 5 min of walking and 1 set of 10 repetitions at approximately 50% of the 1RM. The load was increased gradually (10%--15%) during the test until the participants were no longer able to perform the entire movement, and 3--5 attempts were allowed as previously described ([@b24-jer-14-3-399]). In a randomized manner, the subjects performed two 1RM tests separated by 72 hr: lower body (45º leg press, leg extension, and leg curl) or upper body (bench press, T-bar row and elbow curl), respectively.

The subjects performed three randomized exercise sessions one week after the 1RM test. For the lower body, participants performed 6 sets at 65% of 1RM in the 45º leg press, leg extension, and leg curl, respectively, for the upper body condition, they performed 6 sets at 65% of 1RM in the bench press, T-bar row, and elbow curl, respectively, and for the full body condition, the subjects performed 3 sets at 65% of 1RM in both lower and upper body routines, in this sequence. For all sequences, 90 sec of rest was allowed between trials and exercises and all routines were directly supervised by the research team to ensure proper performance of the respective routines.

Autonomic modulation and blood pressure measurements
----------------------------------------------------

Autonomic modulation was recorded at rest and during recovery (30 min), through heart rate variability expressed by calculated indices in the time and frequency domains. Subjects were instructed to remain in silence, awake, at rest, breathing spontaneously in the supine position before and after the exercise routines, according with [@b16-jer-14-3-399]. After the procedures had been explained, an elastic strap was placed on the subject at the height of the xiphoid process and a heart rate receptor on the wrist (Polar Electro, model RS800, from Polar Electro Oy, Kempele, Finland). This equipment has been previously validated to record beat-to-beat heart rate and heart rate variability analysis ([@b3-jer-14-3-399]).

The temporal recording of the interval between consecutive cardiac beats (interval RR) was submitted to digital filtering using Polar software complemented by manual filtering. Only sets with more than 95% sinoatrial node beats were included in this study ([@b27-jer-14-3-399]). Next, intervals of five minutes with a minimum of 256 RR intervals were analyzed and selected in Kubios software (Biosignal Analysis and Medical Image Group, Department of Physics, University of Kuopio, Kuopio, Finland) ([@b27-jer-14-3-399]).

For the time domain, the analysis included the square root of the mean squared difference between adjacent RR intervals (RMSSD) and standard deviation of all normal RR intervals (SDNN). For the frequency domain, the analysis included spectral components of low frequency (LF: frequency between 0.04 and 0.15 Hz) and high frequency (HF: frequency between 0.15 to 0.4 Hz) expressed in normalized units (nu). Spectral analysis was calculated using Fast Fourier Transform ([@b28-jer-14-3-399]).

Physiologically, RMSSD and HF represents the parasympathetic component of the autonomic nervous system in the time and frequency domain respectively ([@b28-jer-14-3-399]). The SDNN, as a temporal index, represents global variability while LF index, from the frequency domain, represents the action of both components parasympathetic but with predominance of sympathetic branch ([@b28-jer-14-3-399]).

Blood pressure was recorded at rest, immediately postexercise, post-10, and post-30 after exercise. The systolic and diastolic blood pressure (DBP) were measured using an automatic blood pressure monitor (Omron Healthcare brand, Inc., Intellisense, Model HEM 742 INT, Bannockburn, IL, USA), previously validated ([@b5-jer-14-3-399]). The MBP was calculated using (MBP=SBP+\[2×DBP\]/3).

Statistical analyses
--------------------

A 3×4 (condition×time) repeated measures analysis of variance (RMANOVA) with the Bonferroni adjustment for multiple comparisons was used to compare blood pressure and heart rate variability in the three experimental conditions across time. A RMANOVA was used to analyze the absolute differences (delta=post-30 min value minus rest) for SBP, DBP, and MBP, and indices of heart rate variability. Mauchly's sphericity test was used to test this assumption, and a Greenhouse--Geisser correction applied when necessary. The effect sizes were calculated as the mean rest to postexercise change divided by the pooled rest standard deviation, whereby a value of \>0.20 was considered small, \>0.50 moderate, and \>0.80 large and effect sizes for ANOVA were calculated using partial eta squared (*η*^2^) for time. Statistical significance was set at *P*\<0.05. All analyses were performed using the SPSS ver. 10 (SPSS Inc., Chicago, IL, USA) and data are reported as means and standard deviation.

RESULTS
=======

[Table 1](#t1-jer-14-3-399){ref-type="table"} shows the mean and standard deviation values for 24-hr dietary intake and macronutrient intake averaged across three days for each experimental trial as well as performance comparisons. There were no statistically significant differences between any trials for dietary intake.

[Table 2](#t2-jer-14-3-399){ref-type="table"} shows the comparisons of blood pressure in the three experimental conditions and [Fig. 2](#f2-jer-14-3-399){ref-type="fig"} presents the differences in SBP, DBP, and MBP delta during recovery.

For SBP, there was a main effect of time (*F*=8.055, *P*\<0.001, *η*^2^=0.42), with a statistically significant interaction (*F*=2.213, *P*\<0.014). The *post hoc* analysis showed hypotension at post-10 and post-30 min in relation to immediately Postexercise but no differences between conditions were verified (*F*=2.321, *P*=0.121). However, when analyzing the SBP delta, there was a significantly lower SBP for the FB condition compared to the UB condition (*P*=0.004). Effect sizes were large for FB (0.94) and small for LB (0.32) and UB (0.25).

Regarding DBP, there was a main effect of time (*F*=3.414, *P*= 0.006, *η*^2^=0.25) and a statistically significant difference between conditions (*F*=6.121, *P*=0.008), but no significant interaction (*P*\>0.05). Delta analysis showed lower DBP in the FB condition in relation to the LB condition (*P*=0.038). Effect sizes were large for FB (1.01), ranged from moderate to large for UB (0.70), and were small for LB (0.23).

For MBP, there was a main effect of time (*F*=6.965, *P*\<0.001, *η*^2^=0.38) and a statistically significant difference between conditions (*F*=7.966, *P*=0.002), however, no significant interaction was observed (*P*\>0.05). In addition, the MBP delta verified lower values for the FB condition compared to the LB condition (*P*=0.045). Effect sizes were large for FB (1.18), ranged from moderate to large for UB (0.74), and were small for LB (0.33).

[Fig. 3](#f3-jer-14-3-399){ref-type="fig"} shows the comparisons of heart rate variability in the three experimental conditions. For SDNN (msec), there was a main effect of time (*F*=5.796, *P*=0.007, *η*^2^=0.345) with significantly lower values at post-10 and immediately postexercise in relation to rest (*P*\<0.05).

For RMSSD, there was a main effect of time (*F*=42.297, *P*\< 0.001, *η*^2^=0.794) with lower values across time compared to rest and increased values post-30 min of recovery in relation to immediately postexercise and post-10, although maintained at lower values than at rest (*P*\<0.001).

For LF (nu), there was a main effect of time (*F*=50.969, *P*\< 0.001, *η*^2^=0.822) with higher values for all conditions compared to rest (*P*\<0.001). For HF (nu) there was a main effect of time (*F*=51.074, *P*\<0.001, *η*^2^=0.823) with lower HF immediately postexercise, post-10, and post-30 in relation to rest (*P*\<0.001). For all indices analyzed, there were no significant differences between conditions and no significant interaction. Furthermore, when heart rate variability delta was verified during recovery, there were no significant changes in the SDNN (*F*=3.022, *P*= 0.069, *η*^2^=0.216), RMSSD (*F*=2.007, *P*=0.158, *η*^2^=0.154), or LF and HF (*F*=1.316, *P*=0.288, *η*^2^=0.10).

DISCUSSION
==========

The main findings of this study were that a bout of FB RE induced greater PEH than split body RE, since SBP post-30 min of exercise was lower in the FB compared with UB condition and there was a greater reduction in diastolic and MBP after exercise for FB in relation to LB. Regarding heart rate variability, participants presented physiological responses with no differences between the conditions, and a progressive increase in parasympathetic modulation during recovery was observed, in addition to which after 30 min of exercise sympathetic predominance persisted compared to rest.

Investigation into the influence of full versus split body resistance training on PEH is little explored in the literature. [@b23-jer-14-3-399] analyzed the effects of upper versus lower body RE (biceps curl vs. leg extension) with 10 repetitions on PEH. The results showed that only lower body exercise induced significant reductions in the systolic and MBP but no differences were observed between upper and lower body exercise for DBP, however, the authors did not compare the effects with the full body condition. On the other hand, in the present study, we showed that the FB condition induced greater PEH than both split body conditions; thus, our results suggested that the amount of muscle mass involved in a bout of RE can induce different PEH responses.

Clinically, these results have an important practical application, as they could be used to direct the prescription of RE for PEH, using FB training. It has been reported that maintenance of vasodilatation after exercise may influence, in part, PEH ([@b10-jer-14-3-399]; [@b11-jer-14-3-399]). The possible mechanism by which RE with larger muscle mass induced higher PEH could be attributed to the great amount of muscle mass in a condition of vasodilation, leading to a reduction in vascular resistance ([@b11-jer-14-3-399]; [@b20-jer-14-3-399]). In support, the increased blood flow to muscle during exercise can be potentiated by a higher amount of active muscle mass ([@b15-jer-14-3-399]). We hypothesize that the FB routine created an increase in the need for blood flow in the large amount of active muscles, which led to higher vasodilatation in both upper and lower regions, favoring the magnitude of PEH.

Furthermore, the results showed that in the sessions involving UB exercise there was a significant reduction in DBP. Supporting our results, [@b8-jer-14-3-399] showed that upper (bench press, lat pull down, and seated military press) and lower body (back squat, knee extension, and knee curl) RE lead to a reduction in SBP after 50 and 60 min in prehypertensive men, but a significant reduction in DBP following exercise was observed only in upper body exercise. [@b7-jer-14-3-399] found that arm exercise (arm crank ergometer) provided a higher reduction in DBP in sedentary males after exercise compared with leg exercise (elliptical trainer) with 35-min duration at 55%--60% heart rate reserve. In addition, in our study, the FB and UB routines induced a greater decrease in DBP than the LB condition. However, further studies are necessary to investigate the mechanism by which the RE involving upper body region can decrease DBP.

Investigations into the influence of RE with different structures on heart rate variability response are necessary to establish an exercise program for patients at elevated cardiovascular risk. [@b16-jer-14-3-399] investigated the effects of full (leg extension, leg curl, seated row, and chest press) versus upper (seated row and chest press) and lower (leg extension and leg curl) body routines with three sets of 10 repetitions on heart rate variability indices in resistance-trained individuals. The authors observed that postexercise autonomic modulation was similar between conditions, generating a reduction in parasympathetic indices after 25 min of exercise. In accordance, our results showed a progressive decrease in parasympathetic modulation, and a sympathetic predominance that persisted until 30 min during recovery, with no significant differences in the evaluated indices was observed between conditions. Given that heart rate variability also can be used to evaluate cardiovascular overload and stress induced by exercise ([@b4-jer-14-3-399]; [@b26-jer-14-3-399]) and reductions in heart rate variability are related with cardiovascular events such as ventricular arrhythmias and sudden cardiac death as well as increased mortality risk ([@b22-jer-14-3-399]; [@b29-jer-14-3-399]; [@b30-jer-14-3-399]), our results demonstrated that FB routine may be used to decrease blood pressure after exercise without elicit a higher cardiovascular overload compared with split routine, however, caution should be taken when interpreting and applying these results to the general public, manly in cardiac patients, once our study was conducted in healthy trained men.

Despite the importance of our results, some limitations must be considered. First, we evaluated one mechanism of blood pressure control, there are other local mechanisms such as tissues releasing vasodilator substances and vasodilator response from contracting skeletal muscles during exercises which could be investigated. Second, we analyzed heart rate variability and blood pressure only during 30 min after exercise. In this way, we suggest future research to analyze the comparison between acute and chronic full versus split body routines on resting blood pressure and heart rate variability in patients with cardiovascular diseases and which measure other mechanisms of blood flow control.

In summary, PEH was influenced by the amount of muscle mass involved in a bout of RE, as the FB condition induced lower SBP in relation to the UB after 30 min of recovery, as well as greater postexercise reduction in diastolic and MBP compared with the LB condition. In addition, there was a progressive increase in parasympathetic modulation during recovery and a sympathetic predominance that persisted until 30 min after exercise when compared to rest in all conditions. From a practical point of view, a full body routine could be used to potentiate blood pressure reduction after a RE program without elicit a higher cardiovascular overload compared with split body routine in health subjects.
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![Experimental design. BP, blood pressure; HRV, heart rate variability; FB, full body condition, 18 sets at 65% of 1RM, 90 sec of rest; LB, lower body condition, 18 sets at 65% of 1RM, 90 sec of rest; UB, upper body condition, 18 sets at 65% of 1RM, 90 sec of rest.](jer-14-3-399f1){#f1-jer-14-3-399}

![Comparison of systolic, diastolic, and mean blood pressure delta (post-30 minus rest) during recovery. Values are expressed as mean±standard deviation. (A) Systolic blood pressure. (B) Diastolic blood pressure. (C) Mean blood pressure. \*Statistically significant differences between full and upper body conditions. ^\#^Statistically significant differences between full and lower body conditions.](jer-14-3-399f2){#f2-jer-14-3-399}

![Comparison of heart rate variability in the three experimental conditions. (A) The root mean square of successive differences between normal intervals (RMSSD) of consecutive cardiac beats, (B) the standard deviation of normal-to-normal intervals (SDNN), (C) high frequency (HF), (D) low frequency (LF), nu, normalized units. ^a)^All condition were significantly different from rest. ^b)^All condition were significantly different from postexercise. ^c)^All condition were significantly different from post-10.](jer-14-3-399f3){#f3-jer-14-3-399}

###### 

Comparison of dietary intake in the three experimental trials

  Dietary Intake        Trial-1       Trial-2       Trial-3       *P*-value
  --------------------- ------------- ------------- ------------- -----------
  Carbohydrate (g)      288.5±127.4   275.6±115.5   259±115.7     0.192
  Protein (g)           124.5±54.3    123±29.4      111.1±31.7    0.431
  Lipid (g)             69.6±22.5     71.3±25.4     78.2±32.2     0.479
  Total intake (kcal)   2,283±578.3   2,236±558.6   2,185±581.2   0.716

Values are presented as mean±standard deviation.

###### 

Comparison of blood pressure in the three experimental conditions

  Variable      Rest         Post         Post-10                                                                                                    Post-30                                                                                                   Effect size
  ------------- ------------ ------------ ---------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------- -------------
  SBP (mmHg)                                                                                                                                                                                                                                                   
   Upper body   127.3±8.6    137.6±13.1   125.7±10.4[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                    125.4±6.9[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                    0.25
   Full body    129.3±11.8   130.6±23.7   119.2±20.1[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                    119.3±9.5[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                    0.94
   Lower body   128.1±9.4    137.7±15.6   122.3±8.5[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                     124.8±11.3[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                   0.32
                                                                                                                                                                                                                                                               
  DBP (mmHg)                                                                                                                                                                                                                                                   
   Upper body   69.2±9.7     65.2±10.4    57.8±10.7[a)](#tfn4-jer-14-3-399){ref-type="table-fn"},[\*](#tfn6-jer-14-3-399){ref-type="table-fn"}       60.6±12.2[a)](#tfn4-jer-14-3-399){ref-type="table-fn"}                                                    0.70
   Full body    66.8±10.2    66.8±10.2    58.0±10.9^a^,[b)](#tfn5-jer-14-3-399){ref-type="table-fn"},[\*](#tfn6-jer-14-3-399){ref-type="table-fn"}   57.8±7.6^a^,[b)](#tfn5-jer-14-3-399){ref-type="table-fn"},[\#](#tfn7-jer-14-3-399){ref-type="table-fn"}   1.01
   Lower body   68.4±11.2    69.0±5.7     66.2±7.3                                                                                                   66.2±7.9                                                                                                  0.23
                                                                                                                                                                                                                                                               
  MBP (mmHg)                                                                                                                                                                                                                                                   
   Upper body   88.1±7.0     88.9±7.2     80.4±6.3^a^,[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                  82.2±8.9[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                     0.74
   Full body    87.6±7.8     88.1±11.6    78.4±9.8^a^,[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                  75.8±12.2[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                    1.18
   Lower body   88.3±8.6     91.9±5.4     84.9±6.8^a^,[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                  85.7±7.1[b)](#tfn5-jer-14-3-399){ref-type="table-fn"}                                                     0.33

Values are presented as mean±standard deviation.

SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean blood pressure.

Significant difference from rest.

Significant difference from postexercise.

Significant difference from lower body.

Significant difference between full and lower body.
